24 Month Diabetes Log

24-Month Complete Diabetes Self Management Workbook This diabetes journal features: Track blood glucose, meals, health, weight loss and exercise Two years of logs, organized neatly for easy record keeping and reference Detailed Blood Glucose Log Book to keep records throughout the day Daily Food Journal to keep track of what you eat Weekly Weight Loss Log Book with two years of records Nutrient Guide listing calories, fat, carbs and protein for most common foods Medications and Supplements List Calorie Expenditure Table and Daily Calorie Needs List Weight conversions, BMI and blood sugar targets 134 pages 6 x 9 inches (portable and easy to carry) Ten percent of book sales go towards enabling youth in developing countries to access better educational opportunities. This money is being donated to Build to Learn, an initiative started by The Mindful Word.

This small, lightweight and practical Log book will help you to track your blood sugar levels throughout the day. columns include before and after tracking for breakfast, lunch, dinner, and bedtime. Plus a space for daily notes. A blood sugar diary is a valuable tool to communicate with your healthcare providers, and may help reveal trends and patterns that you may not have noticed. Book Features: 2 year blood sugar level tracking Monday to Sunday tracking (week per page) Breakfast (before & after) Lunch (before & after) Dinner (before & after) Bedtime (before & after) Daily notes space 6 x 9 Inches. 105 pages Matte cover

A compilation of data on end stage renal disease (ESRD). With 1990, data includes incidence, mortality, and morbidity by primary diagnosis, treatment modality, and by other sociodemographic variables. Also includes data on kidney transplants and transplant outcomes.

Clinical Dilemmas in Diabetes answers the clinical questions commonly encountered when diagnosing, treating, and managing patients with diabetes and its associated complications. Designed to support informed, evidence-based care, this authoritative clinical guide includes contributions from leading endocrinologists and diabetes researchers that discuss a diverse range of recent developments. Concise and focused chapters cover prediabetes, diabetes diagnosis, initial evaluation and management, disease complications, and cardiovascular disease and risk factors. Now in its second edition, Clinical Dilemmas in Diabetes contains extensively reviewed and revised information throughout. New and updated chapters examine prediction, diagnosis, and management of early Type 1 diabetes, ophthalmic complications, screening asymptomatic patients for cardiovascular disease, new agents for treatment of dyslipidemia, closed loop systems in Type 1 diabetes, upper gastrointestinal manifestations, managing hyperglycemia in critically ill patients, and more. Edited by Dr. Vella at the Mayo Clinic, this highly practical resource: Encourages evidence-based clinical decision-making, rather than algorithm-based approaches Provides clear guidance on common problematic areas, especially in cases where conflicts in treatment for the disease and the complications occur Emphasizes the importance of translating the results of clinical trials to individual care and management of diabetes Contains effective learning and revision tools, including Learning Points, chapter introductions and summaries, tables and figures, color diagrams and charts, and full references Part of the popular Clinical Dilemmas series, Clinical Dilemmas in Diabetes is a must-have guide for anyone involved in the treatment of patients with diabetes, particularly endocrinologists, diabetes specialists and consultants, cardiologists, residents, fellows, specialist nurses, and general practitioners with an interest in diabetes.

After a decade or longer, approximately one-third of individuals with either type 1 or type 2 diabetes commence a downhill course in which decreasing renal function and failing vision define a Renal-Retinal Syndrome, dominating all aspects of life and presaging early death. Only a generation ago, survival after onset of end-stage renal disease (ESRD) in diabetes was limited because rehabilitation was preempted by blindness, limb amputation, stroke, and heart disease. By 1998, however, team management has improved the outlook, with preserved sight and return to work and home responsibilities, usually for a decade or longer, following kidney transplantation and laser photocoagulation. Recognition of the critical requirement for blood pressure regulation and metabolic control are central themes in management. In this unique book, the accomplishments of ophthalmologists, nephrologists, diabetologists, transplant surgeons, and basic scientists are blended into a strategic approach that may be readily applied by all those caring for diabetic patients. Each of twenty-one presentations suitable for primary care physicians, as well as for subspecialists concerned with macrovascular and microvascular complications of diabetes, is placed in perspective by an introductory editorial analysis. Promising near-term innovative therapies, including insertion of genetically engineered beta cells or polymer-coated islets of Langerhans, interdiction of kinins that promote retinal angiogenesis, and prevention of synthesis of advanced glycosylated endproducts (AGEs), are presented in detail. While comprehensive care of diabetic patients reflects multiple incremental advances that in sum afford major benefit, this text envisions further remarkable changes likely to suppress and possibly entirely prevent the Diabetic Renal-Retinal Syndrome.

The economic and human costs of diabetes in the U.S. population place an enormous burden on its healthcare system as well as on employers, diabetics, and their respective families. Many Medicare Advantage plans have responded to this burden by implementing diabetes case management programs (DCMPs) aimed at reducing inappropriate health services utilization, improving health outcomes, and containing costs. While the use of DCMPs is common to many health plans, the research regarding their effectiveness has been sparse or inconclusive. The purpose of this study was to help fill a critical gap in the research literature by evaluating the effect of a diabetes case management program known as CareContact on a Medicare population in Texas. The study population consisted of 2,972 confirmed diabetic members who were continuously enrolled in SelectCare of Texas, a Medicare Advantage plan, for the two-year period between January 1, 2005 and December 31, 2006. To be eligible for this study, diabetic members had to have a minimum of 6 months without exposure to CareContact and 6 months of exposure to CareContact after the initial exposure. Twelve separate cohorts, defined by date of initial program exposure, were evaluated using a one group interrupted time series design. Cross sectional time series analysis, which combines ordinary least square regression techniques and time series analyses, was used to evaluate program effectiveness. After controlling for confounders and the effects of time, the data indicated that membership in the DCMP was associated with increased costs and increased utilization over the two-year study period. The study points to the need for further research into the effectiveness of diabetes case management programs, especially for participants of Medicare Advantage health plans.